Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Stock Quote & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare

Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine based pharmaceutical products. It provides its products to medical applications and diagnostics.

The Power Play by The Market Herald

{{currentVideo.videoCaption}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSXV:VM)

Fundamentals Snapshot (TSXV:VM)

Current News (TSXV:VM)

Advancing environmental work at the Frances Creek barium project

Jon Brown 5 hours ago

Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work at Frances Creek Project Site For Notice of Work & Quarry Permitting

TheNewsWire 6 hours ago

Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs

TheNewsWire 7 days ago

Voyageur Pharmaceuticals Ltd. Files Interim Financial Statements and Grants Deferred Share Units

TheNewsWire April 28, 2023

Voyageur (TSXV:VM) confirms preference for SmoothX in comparative studies

Trevor Abes April 11, 2023

Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of its SmoothX(R) Contrast Media Confirming Product Superiority, and announces Option Grant and AGM Date

TheNewsWire April 4, 2023

View More News ››

Opinion & Analysis (TSXV:VM)

Health Canada Approvals Set Stage for Revenue Generation

Dave Jackson February 25, 2021

From the Earth to the Bottle

Dave Jackson January 21, 2020

VIDEO: High Grade Barite Producer

BTV-Business Television May 18, 2017

View More Opinion ››

Bullboard Posts (TSXV:VM)

quarry permitting

Looks like they are going to apply for a quarry permit soon. Based on news, the work being done is for notice of work and quarry permit...

biggdogg - 3 hours ago

RE:RE:Rain Cage partners with Voyageur ???

Asking because I see phase 2 being mentioned in the comments. Since this C60 is going to be used for attempting to make contrast agents...

postie1 - 5 days ago

The nuts

All I know is that we are sitting with an unbeatable poker hand.

whitenorth72 - 5 days ago

RE:Rain Cage partners with Voyageur ???

The extraordinary minds within Voyageur are undoubtedly engaged in groundbreaking work that holds immense potential for resounding...

biggdogg - 6 days ago

RE:Rain Cage partners with Voyageur ???

Notice in the news release there was no comment from anyone at RC stating how elated they are to partner with VM? Fear not...

oldtrouf - 6 days ago

Rain Cage partners with Voyageur ???

I have been patiently waiting for Voyaguer to make it's move for several years as many longs on this board have. I have seen the...

WarrantOfficer - 6 days ago

View more Bullboard ››

follow v.vm on

PHARMACEUTICALS

COMMON QUESTIONS

View the Presentation

Voyageur Pharmaceuticals | The Power Play

{{currentVideo.videoCaption}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous Video {{moreVideoText}} Next Video >

IR CONTACT

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1